Decline in parallel trade expected by drug companies

06/3/2005 | Reuters

Executives of major drug companies anticipate a decline in parallel trade, the practice of shipping drugs from low-price markets to Europe, where they account for 5% of all EU drug sales. Roche Holding chief Franz Humer said indications of an improvement are "more positive and optimistic," while Sanofi-Aventis chairman Jean-Francois Dehecq predicted parallel trade "will decrease this year."

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations